BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharmaconomics//FDA Catalyst Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
BEGIN:VEVENT
UID:pharmaconomics-556@pharmaconomics
DTSTAMP:20260707T034742Z
DTSTART;VALUE=DATE:20260421
DTEND;VALUE=DATE:20260422
SUMMARY:RAPP Phase 2 — RAP-219
DESCRIPTION:Phase 2 trial results for RAP-219 in bipolar mania are due Apr 21\, 2026. A clean hit validates the program\; a miss can gap the stock down hard.\n\nPrimary source: https://www.sec.gov/Archives/edgar/data/2012593/000119312526167078/rapp-ex99_1.htm\n\nTrack it: https://www.pharmaconomics.com/e/556
URL:https://www.pharmaconomics.com/e/556
TRANSP:TRANSPARENT
BEGIN:VALARM
TRIGGER:-P1D
ACTION:DISPLAY
DESCRIPTION:RAPP catalyst tomorrow
END:VALARM
END:VEVENT
END:VCALENDAR